Home

Bio-Techne Corp - Common Stock (TECH)

62.49
+0.33 (0.52%)

Bio-Techne Corp is a biotechnology company that specializes in developing and producing high-quality biotechnology tools and reagents for the life sciences market

The company offers a wide range of products, including proteins, antibodies, assays, and diagnostic tools, which are used by researchers and clinical laboratories for various applications, such as drug development, diagnostics, and disease research. With a focus on innovation, Bio-Techne aims to provide cutting-edge solutions that enhance research capabilities and improve patient outcomes in healthcare.

SummaryNewsPress ReleasesChartHistoricalFAQ
Lunaphore to Get Acquired by Bio-Techne
Lunaphore Technologies SA, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it has reached an agreement to be acquired by Bio-Techne Corporation (NASDAQTECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The acquisition is anticipated to close in Q3.
By Lunaphore · Via Business Wire · June 22, 2023
Tackling Recurring Health Conditions Offers Hope to Patients
Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly in the case of cancer or heart conditions. This reality is encouraging more companies to seek treatments for recurring conditions. […]
Via FinancialNewsMedia · June 21, 2022
908 Devices and Bio-Techne Announce Joint Collaboration
908 Devices (NASDAQMASS) and Bio-Techne Corporation NASDAQ: TECHNASDAQTECH)
By 908 Devices · Via Business Wire · May 4, 2021